| 334.75 -0.08 (-0.02%) | 05-30 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
ShockWave Medical, Inc. is a medical technology firm that specializes in the development and global commercialization of intravascular lithotripsy (IVL) systems. This innovative approach is designed to treat calcified plaque in individuals affected by peripheral vascular, coronary vascular, and heart valve conditions. The company's product offerings include the M5 catheter for addressing above-the-knee peripheral artery disease, the C2 catheter specifically for coronary artery disease, and the S4 catheter, which targets below-the-knee peripheral artery disease. ShockWave Medical serves a professional clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, leveraging both direct sales teams and distribution partners. The organization was founded in 2009 and is based in Santa Clara, California.
Wed, 23 Sep 2026
Shockwave Medical stock trades without a current quote - AD HOC NEWS
Tue, 22 Sep 2026
Shockwave Medical stock trades without a current quote - AD HOC NEWS
Mon, 06 May 2024
Shockwave Medical Reports First Quarter 2024 Financial Results - GlobeNewswire
Wed, 24 Apr 2024
Shockwave Medical (SWAV) Rose on an Acquisition News and Solid Financial Result - Yahoo Finance
Fri, 05 Apr 2024
Johnson & Johnson to Acquire Shockwave Medical - citybiz
Fri, 05 Apr 2024
J&J Acquires Shockwave Medical to Boost Its Cardiovascular Treatment Portfolio - Investopedia
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|